Bicycle Therapeutics plc (BCYC)

NASDAQ: BCYC · Real-Time Price · USD

5.20

-0.15 (-2.80%)

At close: Mar 6, 2026, 4:00 PM EST

5.30

+0.10 (1.92%)

After-hours: Mar 6, 2026, 7:47 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Developing a Unique Class of Chemically Synthesized Medicines	35.28M	26.98M	14.46M	11.70M	10.39M
Developing a Unique Class of Chemically Synthesized Medicines Growth	30.76%	86.52%	23.65%	12.58%	-24.72%
Total	35.28M	26.98M	14.46M	11.70M	10.39M
Total Growth	30.76%	86.52%	23.65%	12.58%	-24.72%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United Kingdom	35.28M	26.98M	14.46M	11.70M	10.39M
United Kingdom Growth	30.76%	86.52%	23.65%	12.58%	-24.72%
Total	35.28M	26.98M	14.46M	11.70M	10.39M
Total Growth	30.76%	86.52%	23.65%	12.58%	-24.72%

Source: S&P Global Market Intelligence.